Memantine treatment decreases levels of secreted Alzheimer's amyloid precursor protein (APP) and amyloid beta (Aβ) peptide in the human neuroblastoma cells
- 5 February 2010
- journal article
- research article
- Published by Elsevier BV in Neuroscience Letters
- Vol. 470 (1), 1-5
- https://doi.org/10.1016/j.neulet.2009.11.016
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Mild cholesterol depletion reduces amyloid‐β production by impairing APP trafficking to the cell surfaceJournal of Neurochemistry, 2009
- Memantine protects rat cortical cultured neurons against β‐amyloid‐induced toxicity by attenuating tau phosphorylationEuropean Journal of Neuroscience, 2008
- Amyloid Precursor Protein Trafficking, Processing, and FunctionPublished by Elsevier BV ,2008
- Memantine leads to behavioral improvement and amyloid reduction in Alzheimer's‐disease‐model transgenic mice shown as by micromagnetic resonance imagingJournal of Neuroscience Research, 2008
- Effects of Memantine on Neuronal Structure and Conditioned Fear in the Tg2576 Mouse Model of Alzheimer's DiseaseNeuropsychopharmacology, 2008
- Polymodal Regulation of NMDA Receptor-ChannelsChannels, 2007
- Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug MemantineJournal of Biological Chemistry, 2007
- The Experimental Alzheimer's Disease Drug Posiphen [(+)-Phenserine] Lowers Amyloid-β Peptide Levels in Cell Culture and MiceJournal of Pharmacology and Experimental Therapeutics, 2006
- Strategies for examination of Alzheimer’s disease amyloid precursor protein isoformsAnalytical and Bioanalytical Chemistry, 2006
- Memantine Improves Spatial Learning in a Transgenic Mouse Model of Alzheimer's DiseaseJournal of Pharmacology and Experimental Therapeutics, 2004